Question: Please describe your vision of how we may improve women’s health by increasing access to quality, comprehensive cancer care? How can government help catalyze efforts to improve women’s health?
Question: How can partners work with the WHO to support the achievement of the 2030 goals for cervical cancer prevention and control?
Question: How may we get creative and innovative in terms of how we deploy different capital?
Question: How would you put entrepreneurship, industry, policy, and global surgery all together?
Question: How can companies such as Varian develop the necessary partnerships to increase women’s access to the full range of cancer care from awareness, screening, diagnosis and therapeutics?
Question: What has been your experience at Philips in developing partnerships in Kenya and other countries., what has worked out, what are the lessons learned, and how can we move forward and successful partnerships to increase access to care for women and other underserved populations?
Question: How do we bring innovations into the public health sphere?
Question: What is your perspective on challenges and financing on private health initiatives in Fiji?
Question: How would you recommend that the partners work in some of these implementation projects?
Question: What is Roche’s thinking as to how to take the early technology and scale it to move forward with these implementation projects / How can big companies partner with early stage technology?
Question: How do you balance ensuring a decent return as well as achieving social impact?
Question: What do you think investors need to know in order to bring together a project for health care to finance?
Question: Tell us a bit about your approach to women’s health and how do you anticipate brining all key stakeholders, like those in attendance here, to the next steps to get things done on the ground?
Question: What has and hasn’t worked in the process of developing the primary health care model?